IISER Admission 2022: IAT Date Postponed Again
CGBSE results 2022 has announced for class 10th, and 12th board.
MP Board Class 10 & 12 Exams 2022: Result Announced
Karnataka board will declare the SSLC result on 19th May 2022.
SSC MTS & Havaldar Exam 2021: Last Date To Register
KCET 2022: Last Date To Register Tomorrow
Last day for NCHM JEE 2022 registrations.
NEET PG 2022: Admit Card To Release Today
JIPMAT 2022: Registration Starts
TRB Tripura Recruitment 2022: Registration Starts For 300 PGT Posts
Sunday, May, 2022
Home / IIT Mandi Researchers Discover A Molecule Treat Type 1& 2 Diabetes
IIT Mandi Researchers Discover A Molecule Treat Type 1& 2 Diabetes
The Indian Institute of Technology, Mandi's researchers have recognized a drug molecule that can be utilized to treat Diabetes...
by Sukanya Prabhakar / 09 May 2022 11:13 AM IST / 0 Comment(s) / 40
The Indian Institute of Technology, Mandi's researchers have recognized a drug molecule that can be utilized to treat Diabetes. The molecule, named PK2, is able to activate the release of insulin by the pancreas and can possibly be used for Diabetes as oral medicine.
The research team's findings have been printed in the Journal of Biological Chemistry. The Associate Professor of the School of Basic Sciences Dr. Prosenjit Mondal authored the paper along with Prof. of School of Basic Sciences of IIT Mandi Subrata Ghosh and Dr. Sunil Kumar, ICAR- IASRI from PUSA, New Delhi. The other co-authors are Dr. Budheswar Dehury from ICMR RMRC, Bhubaneswar, Dr. Khyati Girdhar, Dr.Abhinav Choubey, Ms. Shilpa Thakur, Dr. Pankaj Gaur, Ms. Bidisha Biswas from IIT Mandi, Ms. Surbhi Dogra, and Dr.Durgesh Kumar Dwivedi from RARI, Gwalior.
Dr. Prosenjit Mondal, while explaining their research, informed that the present-day drugs such as Liraglutide and Exenatide are used for Diabetes and administered as injections. "These drugs are costly and unstable after administration. We seek to find simpler drugs that are stable, cheap, and effective against both Type 1 and Type 2 diabetes", he added.